Cerebral amyloid angiopathy (CAA) can be associated with primary vasculitis of small/medium-sized leptomeningeal and cortical arteries, called CAA-related inflammation (CAA-ri).
Objective:
To compare hemorrhagic and diffusion-weighted imaging (DWI) MRI features in CAA and CAA-ri.
Methods:
We prospectively scored in a consecutive CAA and CAA-ri cohort: presence/number of chronic intracerebral hemorrhage (ICH), cerebral microbleeds (CMB), and cortical superficial siderosis (CSS) on initial T2*-weighted imaging, and DWI lesions on both initial and follow-up imaging. In a subgroup, ApoE, CSF, and 18F-florbetaben-positron emission tomography (FBB-PET) were also analyzed.
Results:
In CAA-ri, CMB presence was more frequent (100% versus 40%, p < 0.001) and CMB numbers higher (mean 137 versus 8, p < 0.001). No difference was observed for chronic ICH or CSS. DWI lesions were more frequent in acute compared to chronic CAA-ri (p = 0.025), whereas no such difference was observed between acute and chronic CAA (p = 0.18). Both ApoE4 (genotyping available in 22 CAA-ri and 48 CAA patients) carriers and homozygosity were more frequent in CAA-ri (48% versus 19% [p = 0.014] and 32% versus 2% [p < 0.001] respectively). CSF biomarker analyses (performed in 20 CAA-ri and 45 CAA patients) showed lower Aβ42 levels in CAA-ri compared to CAA (median 312 versus 422 pg/mL, p = 0.0032). FBB-PET (performed in 11 CAA-ri and 20 CAA patients) showed higher standardized uptake value ratios in CAA-ri compared with CAA, only significant when the pons was used as reference (p = 0.037).
Conclusion:
Compared to CAA, CAA-ri was associated with higher CMB numbers, more frequent ApoE4 carriers and homozygotes, lower CSF Aβ42 levels, and more severe amyloid load on FBB-PET.
ScoldingNJ, JosephF, KirbyPA, MazantiI, GrayF, MikolJ, EllisonD, HiltonDA, WilliamsTL, MacKenzieJM, XuerebJH, LoveS (2005) Abeta-related angiitis: Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain128, 500–515.
2.
ChungKK, AndersonNE, HutchinsonD, SynekB, BarberPA (2011) Cerebral amyloid angiopathy related inflammation: Three case reports and a review. J Neurol Neurosurg Psychiatry82, 20–26.
3.
MelzerN, HarderA, GrossCC, StummerW, NiederstadtT, MeuthSG, MarziniakM, GrauerOM, WiendlH (2014) CD4(+) T cells predominate in cerebrospinal fluid and leptomeningeal and parenchymal infiltrates in cerebral amyloid β-related angiitis. Arch Neurol69, 773–777.
4.
SalvaraniC, HunderGG, MorrisJM, BrownRDJr, ChristiansonT, GianniniC (2013) Aβ-related angiitis: Comparison with CAA without inflammation and primary CNS vasculitis. Neurology81, 1596–1603.
5.
DanveA, GrafeM, DeodharA (2014) Amyloid beta-related angiitis– a case report and comprehensive review of literature of 94 cases. Semin Arthritis Rheum44, 86–92.
6.
SchwabP, LidovHG, SchwartzRB, AndersonRJ (2003) Cerebral amyloid angiopathy associated with primary angiitis of the central nervous system: Report of 2 cases and review of the literature. Arthritis Rheum49, 421–427.
Martínez-LizanaE, Carmona-IraguiM, AlcoleaD, Gómez-ChocoM, VilaplanaE, Sánchez-SaudinósMB, ClarimónJ, Hernández-GuillamonM, MunueraJ, GelpiE, Gómez-AnsonB, de Juan-DelagoM, Delgado-MederosR, MontanerJ, OisA, AmaroS, BlesaR, Martí-FábregasJ, LleóA, ForteaJ (2015) Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: An ARIA before the tsunami. J Cereb Blood Flow Metab35, 710–717.
9.
GreenbergSM, RebeckGW, VonsattelJP, Gomez-IslaT, HymanBT (1995) Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol38, 254–259.
10.
BiffiA, SonniA, AndersonCD, KisselaB, JagiellaJM, SchmidtH, Jimenez-CondeJ, HansenBM, Fernandez-CadenasI, CortelliniL, AyresA, SchwabK, JuchniewiczK, UrbanikA, RostNS, ViswanathanA, Seifert-HeldT, StoegererEM, TomásM, RabionetR, EstivillX, BrownDL, SillimanSL, SelimM, WorrallBB, MeschiaJF, MontanerJ, LindgrenA, RoquerJ, SchmidtR, GreenbergSM, SlowikA, BroderickJP, WooD, RosandJ, International Stroke Genetics Consortium (2010) Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol68, 934–943.
11.
TzourioC, ArimaH, HarrapS, AndersonC, GodinO, WoodwardM, NealB, BousserMG, ChalmersJ, CambienF, MacMahonS (2008) APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology70, 1322–1328.
12.
YuL, BoylePA, NagS, LeurgansS, BuchmanAS, WilsonRS, ArvanitakisZ, FarfelJM, De JagerPL, BennettDA, SchneiderJA (2015) APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol Aging36, 2946–2953.
13.
CharidimouA, Martinez-RamirezS, ShoamaneshA, Oliveira-FilhoJ, FroschM, VashkevichA, AyresA, RosandJ, GurolME, GreenbergSM, ViswanathanA (2015) Cerebral amyloid angiopathy with and without hemorrhage: Evidence for different disease phenotypes. Neurology84, 1206–1212.
14.
CharidimouA, NiJ, Martinez-RamirezS, VashkevichA, AyresA, RosandJ, GurolEM, GreenbergSM, ViswanathanA (2016) Cortical superficial siderosis in memory clinic patients: Further evidence for underlying cerebral amyloid angiopathy. Cerebrovasc Dis41, 156–162.
15.
LoehrerE, IkramMA, AkoudadS, VroomanHA, van der LugtA, NiessenWJ, HofmanA, VernooijMW (2014) Apolipoprotein E genotype influences spatial distribution of cerebral microbleeds. Neurobiol Aging35, 899–905.
RenardD, CollombierL, DematteiC, WacongneA, CharifM, AyrignacX, AzakriS, GaillardN, BoudousqV, LehmannS, de ChampfleurNM, ThouvenotE (2018) Cerebrospinal fluid, MRI, and florbetaben-PET in cerebral amyloid angiopathy-related inflammation. J Alzheimers Dis61, 1107–1117.
22.
CorovicA, KellyS, MarkusHS (2018) Cerebral amyloid angiopathy associated with inflammation: A systematic review of clinical and imaging features and outcome. Int J Stroke13, 257–267.
23.
van VeluwSJ, LauerA, CharidimouA, BounemiaN, XiongL, BoulouisG, FotiadisP, AyresA, GurolME, ViswanathanA, GreenbergSM, VernooijMW (2017) Evolution of DWI lesions in cerebral amyloid angiopathy: Evidence for ischemia. Neurology89, 2136–2142.
DiFrancescoJC, TouatM, CauloM, GallucciM, GarcinB, LevyR, UnciniA, PiazzaF (2015) Recurrence of cerebral amyloid angiopathy-related inflammation: A report of two cases from the iCAβ International Network. J Alzheimers Dis46, 1071–1077.
35.
RenardD, CastelnovoG, WacongneA, Le FlochA, ThouvenotE, MasJ, GabelleA, LabaugeP, LehmannS (2012) Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria. J Neurol259, 2429–2433.
36.
KnudsenKA, RosandJ, KarlukD, GreenbergSM (2001) Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston criteria. Neurology56, 537–539.
37.
LinnJ, HalpinA, DemaerelP, RuhlandJ, GieseAD, DichgansM, van BuchemMA, BruckmannH, GreenbergSM (2010) Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology74, 1346–1350.
38.
AurielE, CharidimouA, GurolME, NiJ, Van EttenES, Martinez-RamirezS, BoulouisG, PiazzaF, DiFrancescoJC, FroschMP, Pontes-NetoOV, ShoamaneshA, ReijmerY, VashkevichA, AyresAM, SchwabKM, ViswanathanA, GreenbergSM (2016) Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation. JAMA Neurol73, 197–202.
39.
GreenbergSM, VernooijMW, CordonnierC, ViswanathanA, Al-ShahiSalman R, WarachS, LaunerLJ, Van BuchemMA, BretelerMM, MicrobleedStudy Group (2009) Cerebral microbleeds: A guide to detection and interpretation. Lancet Neurol8, 165–174.
